February 2016, Switzerland: A jury of entrepreneurs, investors, and scientists has selected InterAx Biotech out of eight projects as a winner of the Venture Kick Final, and a CHF 130,000 investment.
Commenting on the award, InterAx Biotech CEO Dr. Martin Ostermaier said, “Venture Kick was more than winning a price, it was a process in which our team was challenged and during which the business case continuously improved. It helped to expand our network of investors and advisors, and also to connect with other startups. The lessons learned were essential and brought us faster and more focused forward,”
